Introduction
Andro, a diterpenoid lactone, is the major bioactive constituent of the herb Andrographis paniculata and is mainly implicated towards its pharmacological activity [1] . Different Bioactive compounds for cells treatment
The bioactive compounds used were: Andro (97%, HPLC) (Indofine Chemical Company, NJ, USA). Taxi (94%, HPLC) was obtained from Sigma, MO, USA.
Primary and secondary antibodies p-p53 (Ser15), p-JNK (Thr183/Tyr185), PARP, Caspase 3, Caspase 7, Caspase 9, LC3-II, Bcl-2, Bax, Bid and Bim were obtained from Cell Signaling Technology, Beverly, MA. AIF, Cytochrome c, Lamin A/C, CruzFlour (CFL) 647-conjugated anti-mouse, CFL 488-conjugated anti-rabbit and CFL 647-conjugated anti-rabbit were obtained from Santa Cruz Biotechnology, Santa Cruz, CA. GAPDH was obtained from Abcam, Cambridge, UK. β-actin was obtained from Sigma, MO, USA while Cytochrome c was obtained from Invitrogen, CA, USA).
Cell viability using the MTT assay
Cell viability was assessed by using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) (Invitrogen, CA, USA). Cells were seeded at 4000 cells/well into 96 wells plate, incubated in 5% CO 2 at 37˚C for 24 h and the next day the medium was removed and a medium containing drugs was added and the cells were incubated for the indicated period of time. At the end of the treatment, the medium was removed and a medium containing 0.5 mg/ml MTT was added to each well. The plate was then incubated for an additional 4 h. The supernatant was removed at the end of incubation and 100 μl DMSO were added to each well to dissolve the formazan crystals that had formed and the plate was left for 30 minutes. The absorbance was measured at 570 nm using a multi-well scanning spectrophotometer (PowerWave HT, BioTek, USA). Cell viability was expressed as percentage of control by comparing the number of live cells in the treated group to the number in the vehicle control group. CompuSyn software (CompoSyn, Inc., NJ, USA) was used to calculate IC 50 , Combination index (CI) and The Dose Reduction Index (DRI). (The CI > 1 indicates antagonism, CI = 1 indicates additive and CI < 1 indicates synergism.
Apoptotic cell death assay
For quantification of apoptotic cells, the Yo-Pro-1 assay kit (Invitrogen, CA, USA) was used and the procedure provided by the manufacturer was followed. Briefly, the cells were seeded in 60 mm plates and drugs were added after incubation of cells for 24 h. The cells were left incubated for the designated time and then detached from the plate using trypsin, 1x10 6 
Quantification and detection of autophagic vacuoles
For quantification of cells with Acidic Vesicular Organelles (AVOs), the cells were seeded in 60 mm plates and drugs were added after incubation of cells for 24 h. The cells were left incubated for the designated time. Acridine orange was then added to the plates where the final concentration was 1 μg/ml and the cells were incubated for an additional 15 min. Then cells were detached from the plate using trypsin, washed with cold PBS, resuspended in 1 ml PBS and AVOs were quantified using the flow cytometer and the results analyzed using CellQuest software. The red fluorescence of the cells increases as the number of AVOs increase. On the other hand, the AVOs were detected in the cells by using Cyto-ID Autophagy Detection Kit (Enzo Life Sciences, France). The Cyto-ID Green detection reagent serves as a selective marker of autophagosomes and autolysosomes. The protocol provided by the manufacturer was followed. Briefly, the cells were grown on sterile coverslips and the drugs were added after 24 h of incubation. The cells were left incubated for the designated time, and then the medium was removed, cells were washed twice with assay buffer. Then 100 μl of assay buffer containing Cyto-ID Green detection reagent (2 μl/ml) and Hoechst 33342 (1 μl/ml) were added and cells incubated for 30 min. Later, the cells were washed with 100 μl assay buffer, mounted on microscope slides and analyzed using the Leica TCS SPE confocal microscope (Leica Microsystems, Wetzlar, Germany). 
Transmission Electron Microscopy (TEM) analysis

Measurement of ROS
The cells were seeded into 60 mm plates, treated and incubated for the designated time. The 2 0 ,7 0 -dichorofluorescein diacetate (DCF-DA) was added to the cells (10 μM) in the last 30 min of drug exposure. DCF-DA is de-esterified intracellularly and turns to highly fluorescent compound (DCF) upon oxidation. After the designated time of incubation, the cells were harvested, washed and resuspended in ice-cold PBS. PI (5μg/ml) was added for gating the viable cells and the cells were incubated for another 10 min. The DCF fluorescence was then determined by the flow cytometer and the results were analyzed using the CellQuest Software.
JC-1 Staining
The cells were seeded into 60 mm plates, treated and incubated for the designated time. Then the cells were harvested, washed and resuspended in PBS. The cells were then labeled with the JC-1 reagent (4 μM) (Invitrogen, CA, USA) for 15 min at 37˚C. After washing, cells were resuspended in PBS and the fluorescence was measured using the flow cytometer and the results were analyzed using the CellQuest Software. The stained cells were observed by growing the cells on coverslips, treatment for the desired time and then staining using JC-1 for 30 min. The coverslips were then mounted on microscope slides and the slides observed using the fluorescence microscope (Zeiss Axioskop, Mikron Instruments, NY, USA). JC-1 enters into mitochondria and reversibly change color from green to red as the membrane potential increases. In healthy cells with high mitochondrial membrane potential (MMP), JC-1 spontaneously forms complexes known as J-aggregates with intense red fluorescence. On the other hand, in apoptotic or unhealthy cells with low MMP, JC-1 remains in the monomeric form, which shows only green fluorescence.
Protein lysate of cytoplasm and nucleus
Nuclear and cytoplasmic lysates were prepared according to the protocol from the company (Cayman Chemical, Ann Arbor, MI, USA). Briefly, cells were seeded in 100 mm plates and treated with the specified compounds after 24 h and left for the specified time. Cells were collected using scrapper, counted, washed 2 times with cold PBS containing phosphatase inhibitors and then ice-cold hypotonic buffer was added to the pelleted cells. Nonidet P-40 was added, tubes were centrifuged briefly and supernatant was collected (cytoplasmic fraction). Then the pelleted nuclei were lysed using ice-cold extraction buffer containing a mixture of protease and phosphatase inhibitors. Tubes were then centrifuged at 14000 x g for 10 minutes at 4˚C and the supernatant was collected (nuclear fraction). Then the protein concentration was measured and the lysates were aliquoted and stored at -20˚C.
Western blotting
Total cell lysate was prepared by lysing the cells in RIPA lysis buffer (150 mM NaCl, 0.1% SDS, 0.5% Sodium Deoxycholate, 1% NP-40, and 50 mM Tris-Cl, pH 7.5) supplemented with the Protease Inhibitors Cocktail Set III and 1 mM PMSF at a density of 1 x 10 7 cells/ml buffer. The cell suspension was agitated for 30 min and then centrifuged at 12,000 rpm for 20 min at 4˚C. Then the supernatant was transferred to a new tube and stored at -20˚C. The protein concentration was measured using DC protein assay kit (Bio-Rad, CA, USA). Next, 50 μg of protein from the cell lysates were separated by 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto nitrocellulose membranes (Bio-Rad, CA, USA). The membrane was blocked with 5% non-fat milk (Nestle, Switzerland) in PBS with 0.05% tween-20. This was followed by incubation overnight with a diluted solution of primary antibody. This was followed by incubation at room temperature with HRP-conjugated antibody (anti-mouse IgG or anti-rabbit IgG) (Cell Signaling Technology Beverly, MA) for 1 h. At least two independent experiments were performed. The blots were visualized by enhanced chemiluminescence (ECL) using the Western Blotting Luminol Reagent (GE Healthcare, UK). Images developed were captured with an LAS-4000 gel documentation system (Fuji Film, Tokyo, Japan).
Statistical analysis
Statistical analyses were performed by Student 0 s t-test using the Origin 8.5 software (Originlab Corporation, Northampton, MA, USA) and Microsoft Excel program. All numerical data were presented as mean ± SD from at least 3 independent experiments. P-values of less than 0.05 were considered as significant.
Results
Effect of Andro combined with different flavonoids on HeLa cells
A screening study was done to test the combination effects of Andro with different flavonoids (Taxi, silibinin, quercetin, apigenin and luteolin) (data not shown). The combination effect of Andro with Taxi on growth inhibition of HeLa cells was synergistic at all tested combination ratios. Therefore we decided to study further and in more details the synergistic effects of this combination and to investigate the mechanism involved.
Taxi synergized the antiproliferative effect of Andro on HeLa cells
Andro and Taxi inhibited the proliferation of HeLa cells in a dose-and time-dependent manner ( Fig 1A and 1B) but, Taxi effect was much lower than Andro. The calculated IC 50 of Andro and Taxi were 123 μM and 2 mM (24 h) while 51 μM and 310.5 μM (48 h) respectively.
The combination of 50 μM Andro with 100 μM Taxi decreased the viability of cells from 80.3% to 55.1% (Combination index [CI]%0.5) and from 47.9% to 28.5% (CI%0.43) after treatment for 24 and 48 h respectively (Fig 1C) . The dose reduction index (DRI) for the combination of Andro and Taxi which affected 75% of the cells after 48h treatment was 2.7 (the dose of Andro was reduced from~135 to 50 μM) and 15.5 (the dose of Taxi was reduced from 1.5 mM to 100 μM) respectively ( Fig 1D) . The total combination concentration of Andro and Taxi at the different combination ratios 1:1, 1:2 and 1:4 which affected 75% of the cells were 127, 143.1 and 263.4μM with CI values 0.53, 0.43 and 0.53 respectively. Therefore, we chose the combination ratio of 1:2 which gave the best CI value. The concentrations of Andro and Taxi used to study further the effects of the combination were 50 μM and 100 μM respectively for the subsequent experiments. apoptosis in HeLa cells after treatment for 24 h with an increase in the mean percentage of early apoptotic cells at 25 μM and a decrease at concentrations 50 μM and 100 μM due to the increase in late apoptotic cells (Fig 2A and 2B ). Early and late apoptosis were increased in combined-treatment compared to treatment with Andro alone (Fig 2C and 2D ). The involvement of caspases in Andro-induced apoptosis was then examined. Andro caused an increase in the cleaved-PARP and other caspases as the concentration increased from 0-100 μM (Figs 2E and S3). Cells treated with 50 μM Andro and 100 μM Taxi for 24 h, increased the cleaved-PARP (~1.8-folds) and the cleaved-caspase-7 (~3-folds) compared to treatment with Andro alone (Figs 2F and S3A-S3C). The pan-caspase inhibitor, Z-Vad-Fmk, didn't completely inhibit the apoptosis induced by Andro and/or Taxi (Fig 2G and 2H ). The pretreatment with Z-Vad-Fmk attenuated completely caspase-7 cleavage and partially PARP cleavage in cells treated with 50 μM Andro and/or 100 μM Taxi (Figs 2F and S3E and S3F). Accordingly, these results suggest that the apoptosis induced by Andro alone or Andro combined with Taxi is partly mediated by caspase-dependent pathway and that the caspase-independent pathway may be also involved in the death process.
Taxi enhanced Andro-induced apoptosis in HeLa cells
Andro induced autophagy in HeLa cells while Taxi attenuated it
Autophagy may act either as prosurvival or prodeath signal [37] [38] [39] [40] [41] . Different techniques were used to detect the Andro-induced autophagy in HeLa cells as indicated in materials and methods. Firstly, Andro increased the mean percentage of AVOs in a time-and dose-dependent manner (Fig 3A and 3B) . Secondly, TEM revealed the appearance of double-membranous cytoplasmic vacuoles (white arrows) with some showing entrapped organelles after Andro treatment for 24 h (Fig 3C) . Thirdly, Andro increased LC3-II form detected using western blotting ( Figs 3D and S3G) . Finally, punctuate green fluorescence patterns appeared (white arrows) in cells treated with Andro (Fig 3E) . On the other hand, the combination of Andro with Taxi decreased autophagy significantly in a time-and dose-dependent manner (Fig 3F-3H ). This was further confirmed by the decrease in punctuate green fluorescence patterns in cells (Fig 3I) .
Andro induced-protective ROS-dependent autophagy
Andro induced ROS generation in HeLa cells after 24 h treatment while Taxi attenuated it ( Fig  4A and 4B ). The addition of NAC (5 mM) to the cells treated with Andro attenuated the ROS generation and returned the ROS levels roughly to the basal control level (Fig 4C) . On the other hand, Taxi attenuated the Andro-induced ROS generation at different time points (Fig  4D and 4E ). The addition of NAC to the cells treated with different concentrations of Andro abolished almost completely autophagy represented by the decrease in AVOs (Fig 4F and 4G) . This was further confirmed by the abolished conversion of LC3-I to LC3-II and the disappearance of green punctate patterns (Figs 4H and 4I and S3H).
Subsequently, we investigated whether Andro-induced autophagy is a prosurvival or a proapoptotic signal. MTT results show that the pretreatment of cells with chloroquine (5 μM) followed with Andro alone or in combination with Taxi for 24 h decreased the cell viability (Fig 5A) meanwhile viability was increased when cells were pretreated with rapamycin ( Fig  5B) . Taken together, the results confirm that Andro-induced autophagy is ROS-dependent and protective in HeLa cells.
Inhibition of autophagy increased the apoptosis in HeLa cells via the reduction of p-p53
Hela cells treated with Andro and CQ (5 μM) increased the cleaved-PARP (1.25-folds), cleaved-caspases-3 (2-folds) and cleaved-caspase-7 (1.5-folds) compared to treatment with Figs 5C and S3I-S3K) . Whereas, the concentration of p-p53 increased to 9.1-folds (Andro-treated) and decreased to 6.8-folds (combined-treatment) compared to the control ( Figs 5D and S3L) . Recently, p53 was found to be involved in the regulation of autophagy. Therefore, we asked if p53 is involved in the combined-treatment reduced autophagy or not. PFT-α was used, specifically inhibits p53, to test the effect of inhibition of p53 on the viability and autophagy in HeLa cells. Cells pretreated with 30 μM PFT-α and then with Andro and/or Taxi for 24 h caused a significant decrease in their viability (Fig 5E) . Meanwhile, cells pretreated with PFT-α, and then with Andro and/or Taxi caused a decrease in the mean AVOs percentage which was significant at 50 μM Andro and in the combination treatment (Fig 5F) . These results confirm that p53 has a role in Andro-induced autophagy and also confirm that the reduction in autophagy due to the combined-treatment is caused by the reduction in p53.
JNK has a role in Andro-induced cell death but not in autophagy Treatment of cells with Andro alone or combined with Taxi increased the p-JNK by 3.9-folds and 14.7-folds respectively compared to the control (Figs 5H and S3M ). The use of SP600125 (JNK inhibitor) increased the viability of HeLa cells significantly but did not rescue the cells completely from the effect of Andro alone or in combination (Fig 5I) . On the other hand, SP600125 did not have any significant effect on autophagy in cells treated with Andro and/or Taxi (Fig 5I) . Accordingly, the results show that Andro combined with Taxi increased the concentration of p-JNK which may have a role in the induced cell death but is not involved in the induction of autophagy.
Taxi enhanced the MMP loss induced by Andro in HeLa cells while JNK inhibitor reduced it
Andro caused a dose-and time-dependent MMP loss due to the increase in MOMP (Fig 6A-6C) . HeLa cells treated with Andro combined with Taxi further increased the loss of MMP (Fig 6E and 6F) . This was further confirmed by the fluorescence microscope where the JC-1 probe was used (Fig 6D and 6G) . This trend was also found when HeLa cells were pretreated with 3-MA and then with Andro (Fig 6H) . On the other hand, treatment of HeLa cells with Andro alone or in combination with Taxi in the presence of SP600125 caused a decrease in the MMP loss. This further confirms that the increase in the p-JNK is involved in the increase loss of MMP (Fig 6I) . Effect of Andrographolide and Taxifolin on autophagy and cell death in HeLa cells (Fig 7A) which was 2-folds more in the combined-treatment compared to Andro alone. Whereas, cytochrome c translocation from the cytoplasm to the nucleus was minor (Fig 7A and 7B) , the cytoplasmic cytochrome c concentration increased in the combination treatment compared to treatment with Andro alone ( Figs  7C and S3N and S3O ). The proapoptotic protein Bid was cleaved in cells treated with Andro alone or with Andro combined with Taxi. There was also an increase in Bim (L) and Bim (S) proteins concentration in cells treated with Andro (1.2-and 1.4-folds respectively) and when Andro combined with Taxi (1.6-and 1.7-folds respectively) compared to the control (Figs 7D and S3P-S3T).
Discussion
The combination effect of Andro with Taxi on growth inhibition of HeLa cells was synergistic at all tested combination ratios contrast to the results of other flavonoids (silibinin, quercetin, apigenin & luteolin) which ranged from antagonism to synergism depending on the combination ratio and the concentrations used. In fact, the flavonoid concentration is an important factor in its mode of action, the effect it will exert on cells and also on its interaction with other compounds [42] .
The combined-treatment of Andro with Taxi led to a higher early and late apoptosis compared to treatment with Andro alone (Fig 2C and 2D) . However, the early apoptosis results were not compatible with the MTT antiproliferation results which suggested the involvement of caspase-independent cell death. This was confirmed by using Z-Vad-Fmk (Fig 2G and 2H ) and western blotting (Fig 2F) . It is widely accepted nowadays that the tumor response to therapy is a heterogeneous model where various modes of death combine to generate the overall tumor response [43] . The factors which determine the mechanisms of cell death include mechanism of action of the drug, dosing regimen used, and the genetic background of the cells within the tumor [43] .
Recently, different studies have found diverse effects of autophagy on cancer cells, either survival or death, depending on the cancer and on the environment around the cancer cells [44] . Two studies have shown controversial results of Andro on autophagy induction in different cancer cell lines [33, 34] . Our results confirmed that Andro induced autophagy in Hela cells (Fig 3A-3E) . On the other hand, the combination of 50 μM Andro with 100 μM Taxi caused a significant decrease in autophagy (Fig 3F-3I) . Moreover, the decrease in autophagy in the combination treatment was not cell-type specific (S2 Fig). The results also showed that the induction of autophagy is ROS-dependent (Fig 4G-4I) Effect of Andrographolide and Taxifolin on autophagy and cell death in HeLa cells [10, 45] . Conversely, Taxi was shown to act as an antioxidant and decreased ROS production [46] . The combined-treatment of Andro and Taxi caused a decrease in ROS generation (Fig 4E) and at the same time reduced autophagy (Fig 3F-3I) . Thus, the antioxidant effect of Taxi which caused the decrease in ROS generation caused a reduction of Androinduced autophagy. In general, most of the dietary supplements have health-improving effects generally via strengthening the cellular antioxidant system in the body [47] . Those dietary supplements which also possess anticancer activity have more advantage and may give better results in combination chemotherapy [47] . In our study, Taxi worked as both antioxidant and anticancer agent against HeLa cells and these characteristics may be responsible for its ability to synergize the effects of Andro.
Our results showed that Andro induced protective-autophagy in which its inhibition decreased cell viability while increased apoptosis of HeLa cells (Fig 5A and 5C ). These results further confirm that Taxi acted as an inhibitor of autophagy whenever combined with Andro and consequently, the increase in caspase-dependent apoptosis is attributed to this inhibition. Therefore, our results agree with many studies which demonstrated the autophagy-protective role in chemoresistant apoptosis [37-39, 48, 49] while disagree with others who indicated that cell death was due to autophagy and not apoptosis [50] . Many factors are involved in determining the destiny of the cells including the type of stimuli, nutrient availability and apoptotic status of cells [51] . Therefore, the determination of a drug's effect on autophagy may be an important factor in knowing the major impediments to a successful cancer therapy.
At the molecular level, different molecules are involved in autophagy induction including p53 and JNK. In addition to the known functions of p53, the most important being cell cycle arrest and apoptosis, it was also recently found to be involved in the regulation of autophagy [52] [53] [54] . In the present study, we confirmed by using the p53 inhibitor, PFT-α, that p53 has a role in Andro-induced autophagy where the inhibition of p53 caused a decrease in autophagy. This agrees with many studies which showed that ROS and p53 are playing important roles in the induction of autophagy [41, 55] . Our results also confirm that the reduction in autophagy due to the combined-treatment is caused by the reduction in p53. This was further confirmed by the results of MTT which showed that the inhibition of p53, which caused reduction in autophagy, also caused a decrease in the viability of HeLa cells and further confirms that Andro-induced autophagy is protective.
On the other hand, JNK was shown to have a critical role in autophagy [55, 56] . Our results showed that Andro combined with Taxi increased the cytotoxic effect on HeLa cells through the activation of JNK where the inhibition of JNK by SP600125 increased the cell viability ( Fig  5I) . The results also showed that the activation of JNK is not involved in autophagy (Fig 5J) . Our results disagree with those of Notte et al. who found that JNK promoted survival for the MDA-MB-231 breast cancer where the cells became resistant to taxol-induced apoptosis due to JNK activation while agree with them in that JNK plays no role in the induction of autophagy [57] . In contrast, our results agree with those of Shimizu et al. and He et al. who found that the activation of JNK is involved in the cell death and that the use of JNK inhibitor suppressed it [56, 58] . The phosphorylation and stabilization of p53 was reported to be regulated by JNK [59, 60] . In contrast, other reports indicated that the activation of JNK can reduce p53. In fact, our results showed that the activation of JNK reduced the p-p53. This agrees with Wang et al. results who reported that Short-chain fatty acid mixes sustained the activation JNK1 and downregulation of p53 [61] . Tafolla et al. also found that JNK1 and JNK2 are opposite regulators of p53 where JNK1 is a negative regulator while JNK2 is a positive regulator of p53 expression [62] .
The involvement of mitochondrial-events in autophagy process was reported in many studies [33, 38] . The treatment of HeLa cells with Andro caused an increase in the MMP loss ( Fig  6B) which was augmented by either the addition of Taxi (Fig 6F) or 3-MA (Fig 6H) . Therefore, the decrease in autophagy augmented the loss of MMP. Similar results were shown by different groups and on different cancer cells where 3-MA increased the MMP loss when used with cisplatin, 5-FU [36] or with bortezomib [63] . The results showed that the treatment of HeLa cells with Andro and/or Taxi combined with SP600125 decreased the MMP loss. This further confirms that the increase in JNK-activation disrupted the mitochondria, increased the MMP loss, and increased the release of caspase-dependent and independent factors which caused cell death in HeLa cells. These results confirm further the important role of mitochondria in the cell death and further confirm the significance of autophagy in reducing the caspase-dependent and independent cell death by reducing the number of mitochondria by sequestration and destructing them in the autophagosomes.
The results also showed that AIF was translocated from the cytoplasm to the nucleus in the cells treated with Andro alone or Andro combined with Taxi, however the translocation was minor in the case of cytochrome c (Fig 7A and 7B) . This was further confirmed by western blotting (Fig 7C) . In the case of cytochrome c, there were higher levels of cytoplasmic cytochrome c in the cells treated with Andro combined with Taxi compared to treatment with Andro alone. The results confirm that there was another mechanism of cell death together with the caspase-dependent mechanism which is caspase-independent and related to the release of AIF and its translocation to the nucleus. These results coincide with many reports which also indicated that AIF is involved in caspase-independent cell death [38, 64] .
In conclusion, the effects of Andro alone or in combination with Taxi on HeLa cells were investigated. Taxi, which has a low cytotoxic effect, synergized the cytotoxic effect of Andro by attenuating ROS and autophagy, increasing MMP loss, the release of AIF and cytochrome c and the caspase-dependent and independent cell death whenever they are in combined use. Based on the results, a proposed pathway for cell death was formulated (Fig 8) . To our knowledge, the present study has shown for the first time that Andro can induce protective autophagy in HeLa cells and that the autophagy reduced by Taxi can improve the cytotoxic effect of 
